SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-15-005809
Filing Date
2015-11-05
Accepted
2015-11-05 16:37:19
Documents
14
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 510187
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 13968
3 EXHIBIT 10.2 exhibit10-2.htm EX-10.2 203691
4 EXHIBIT 10.3 exhibit10-3.htm EX-10.3 14594
5 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 7515
6 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 7838
7 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2502
8 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 2651
  Complete submission text file 0001062993-15-005809.txt   4080543

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE abus-20150930.xml EX-101.INS 572494
10 XBRL SCHEMA FILE abus-20150930.xsd EX-101.SCH 52396
11 XBRL CALCULATION FILE abus-20150930_cal.xml EX-101.CAL 36768
12 XBRL DEFINITION FILE abus-20150930_def.xml EX-101.DEF 311884
13 XBRL LABEL FILE abus-20150930_lab.xml EX-101.LAB 445456
14 XBRL PRESENTATION FILE abus-20150930_pre.xml EX-101.PRE 331235
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 151201258
SIC: 2834 Pharmaceutical Preparations